Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection

被引:8
|
作者
Beckebaum, S
Cicinnati, VR
Karliova, M
Dirsch, O
Erim, Y
Frilling, A
Malago, M
Broelsch, CE
Treichel, U
Gerken, G
机构
[1] Univ Hosp Essen, Dept Gen Surg & Transplantat, D-45122 Essen, Germany
[2] Univ Hosp Essen, Dept Gastroenterol & Hepatol, D-45122 Essen, Germany
[3] Univ Hosp Essen, Dept Pathol, D-45122 Essen, Germany
[4] Univ Hosp Essen, Dept Psychotherapy & Psychosomat, D-45122 Essen, Germany
关键词
D O I
10.1016/S0041-1345(03)00681-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2080 / 2081
页数:2
相关论文
共 50 条
  • [41] Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection
    Battaglia, AM
    Hagmeyer, KO
    [J]. ANNALS OF PHARMACOTHERAPY, 2000, 34 (04) : 487 - 494
  • [42] Is Combination Therapy Interferon and Ribavirin in Patients with Chronic Hepatitis C Infection Toxic for Eyes?
    Mousa, Nasser
    Besheer, Tarek
    Gad, Yahia
    Elbendary, Amal
    Mokbel, Tharwat
    Abdel-Aziz, Azza
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (03) : 345 - 348
  • [43] Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis
    Naoki Hiramatsu
    Masayuki Kurosaki
    Naoya Sakamoto
    Manabu Iwasaki
    Minoru Sakamoto
    Yoshiyuki Suzuki
    Fuminaka Sugauchi
    Akihiro Tamori
    Sei Kakinnuma
    Kentaro Matsuura
    Namiki Izumi
    [J]. Journal of Gastroenterology, 2011, 46
  • [44] Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis
    Hiramatsu, Naoki
    Kurosaki, Masayuki
    Sakamoto, Naoya
    Iwasaki, Manabu
    Sakamoto, Minoru
    Suzuki, Yoshiyuki
    Sugauchi, Fuminaka
    Tamori, Akihiro
    Kakinnuma, Sei
    Matsuura, Kentaro
    Izumi, Namiki
    [J]. JOURNAL OF GASTROENTEROLOGY, 2011, 46 (09) : 1111 - 1119
  • [45] Daily administration of interferon alpha 2b and utility of combination therapy with ribavirin as initial treatment for chronic hepatitis C.
    Ricchiuti, A
    Ciccorossi, P
    Costa, F
    Bellini, M
    Carrara, PD
    Arpe, P
    Maggi, F
    Vatteroni, ML
    Bendinelli, M
    Maltinti, G
    Marchi, S
    [J]. HEPATOLOGY, 1999, 30 (04) : 627A - 627A
  • [46] Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study
    GianPiero Benetti
    Mauro Borzio
    Giuliano Ramella
    Giorgio Bellati
    Silvia Fargion
    Alberto Colombo
    Guido Croce
    Carlo Iamoletti
    Federico Balzola
    Mario Rizzetto
    [J]. Internal and Emergency Medicine, 2006, 1 : 113 - 118
  • [47] Treatment of acute hepatitis C with pegylated interferon alpha-2b and ribavirin
    Capozza, TA
    Brann, OS
    Coyle, WJ
    Schindler, WR
    BeMiller, TA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S188 - S188
  • [48] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [49] Preemptive therapy with combination of interferon and ribavirin in liver transplant recipients with hepatitis C
    Dono, Keizo
    Marubashi, Shigeru
    Kobayashi, Shogo
    Nagano, Hiroaki
    Monden, Morito
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 290 - 290
  • [50] Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study
    Benetti, GianPiero
    Borzio, Mauro
    Ramella, Giuliano
    Bellati, Giorgio
    Fargion, Silvia
    Colombo, Alberto
    Croce, Guido
    Iamoletti, Carlo
    Balzola, Federico
    Rizzetto, Mario
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2006, 1 (02) : 113 - 118